"First advance orders for new MPDD devices are now being received from physicians and the Company is anticipating very strong demand in 2013 after worldwide distribution release. The MPDD devices will initially be marketed under the therapeutic label and later will be marketed under the diagnostic label with an additional FDA 510k. MPDD devices will be priced between $12,000.00 and $20,000.00 depending on the package level of training and education purchased by physicians and health organizations."
Wow...August 30th,2012 huh? That's almost 3 years of lies by EPGL in my opinion. But never mind...here's what EPGL says about shareholders:
"Shareholders are the most important asset to EPGL Med.Shareholders can expect additional announcements shortly about additional management personnel, new offices and new name."